CEO Roundtable: Boulder Valley life sciences industry shines amid COVID crisis
BOULDER — The COVID-19 pandemic is providing an opportunity for the Boulder Valley’s life sciences industry — from pharmaceutical firms, to medical device makers, to University of Colorado research laboratories — to remind the world that this little region in the shadows of the Flatirons punches above its weight.
“We have the infrastructure, support and clearly the people” to compete alongside more established strongholds on the coasts, Novartis Gene Therapies plant manager Sally Dyer said Thursday when biotech executives gathered virtually to discuss the state of the industry during BizWest’s Life Sciences CEO Roundtable.
It’s been a busy…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
BOULDER — Even with the COVID-10 pandemic several years in the rearview mirror, it remains…
-
Biopharmaceutical company AmideBio LLC has received a $1.93 million grant from the federal government for…
-
Boulder Community Health this month became the first facility in Colorado to offer patients a…
-
Columbine Health Systems will host Dementia Week, a series of free events devoted to educating…
